Other languages SI-BONE, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-29 EDT			5-day change	1st Jan Change
14.65 ^USD	+0.55%		-5.85%	-30.20%

03-28	Piper Sandler Initiates SI-Bone With Overweight Rating, Price Target is $25	MT
03-12	Transcript : SI-BONE, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:30 AM

SI-BONE, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-26
SI-BONE, Inc. Provides Earnings Guidance for the Year 2024	02-26
Si-bone Insider Sold Shares Worth $808,591, According to a Recent SEC Filing	02-21
SI-Bone Implant Receives Expanded FDA Approval	01-30
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application	01-30
SI-Bone, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023	01-08
SI-BONE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-06
SI-BONE, Inc. Increases Earnings Guidance for the Full Year 2023	11-06
Si-bone Insider Sold Shares Worth $423,738, According to a Recent SEC Filing	23-10-04
SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera 5.5/6.0 System Rods	23-09-05
Insider Sell: Si-bone	23-08-18
Insider Sell: Si-bone	23-08-18
Insider Sell: Si-bone	23-08-18
Insider Sell: Si-bone	23-08-15
SI-BONE, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07
SI-BONE, Inc. Revises Revenue Guidance for the Year 2023	23-08-07
Insider Sell: Si-bone	23-05-18
Insider Sell: Si-bone	23-05-18
Insider Sell: SI-Bone	23-05-11
Top Midday Gainers	23-05-02

No results for this search